Indivior Knew Suboxone Film Did Not Have Greater Child Safety Than Tablet, Grand Jury Claims
Executive Summary
Indictment alleges Indivior falsely cited concerns about pediatric exposure to tablets in discontinuing the formulation; FDA official says company tried to mislead agency and bar competition for Suboxone.